Montreal, September 20, 2018 – IRICoR is proud to launch, today with the Oncopole, this new LeadAction-Onco Competition. This joint call for projects, in partnership with the FRQS, is an opportunity for researchers from Quebec and the rest of Canada to accelerate the transformation of their projects in oncology and immuno-oncology into novel therapies […]
Dr. Nadine Beauger, Chief Executive Director and Dr. Steven Klein, Vice President, Business Development at IRCoR, took part in a Q&A session to discuss the key strengths and benefits of IRICoR’s model, its achievements and the partnerships created over the past 10 years, as well as the organization’s vision for the next 5 years, in the August-September 2018 edition of […]
Montreal, July 30, 2018 — IRICoR (Institute for Research in Immunology and Cancer – Commercialization of Research), a drug discovery and commercialization cluster, is proud to announce that it has received substantial support from the federal government in the amount of 25 million dollars, as part of the 2018 edition of the Centres of Excellence for Commercialization and Research program […]
Montreal, June 5, 2018 – The Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR) and its host institution, the Université de Montréal (UdeM) today announced that they have entered into a research collaboration with AbbVie, a global research and development-driven biopharmaceutical company, in order to identify Tumor-Specific Neoantigens (TSNA) based on a novel proprietary platform developed […]
In collaboration with the Québec Government Office in Brussels, the Minister of Economy, Science and Innovation (MESI), organizes an economic mission in research in innovation in the life sciences sector, happening from May 14th to 17th 2018. Nadine Beauger, Chief Executive Officer of IRICoR is a member of the delegation.
This mission will allow the attending Quebec organizations to take […]
As part of CHU Ste-Justine’s Quality & Innovation Week, Nadine Beauger, IRICoR’s Executive Director, shared her experience and her career as a woman and scientist in the business world, at the Entrepreunariat Career Evening as guest speaker.
The “Entrepreunariat” career evening was held during a journey under the theme Personalized Health and highlighted promising initiatives and new targeted health solutions.
As Université […]
IRICoR is proud to announce the Dr. Steven Klein, Vice-President Business Development at IRICoR is invited as a speaker at the next Licensing Executives Society – France workshop to be held April 04, 2018 in Paris.
This half-day conference focus on “Agreements between Biotech and University and between Pharma and Biotech:” what to do and what not to do “”, among […]
Montreal, March 28, 2018 — IRICoR is delighted by the government’s show of support, in the amount of $12.3M, enabling it to carry out its research project maturation activities in oncology and in immunology for the purpose of establishing partnerships with industry.
“We are proud to be able to rely on this substantial assistance from the Government of Quebec, allowing us […]
Montreal, March 22, 2018 – The Oncopole and IRICoR have joined forces to launch the Scholarship Competition – Entrepreneurship in Oncology (CEO), offering the next generation of scientists an opportunity to take part in the first cohort of the new Life Sciences Entrepreneurship Development Program.
This practical and immersive program was launched by Montréal InVivo, Université de Montréal’s Faculty of Pharmacy […]
Nadine Beauger, Chief Executive Officer of IRICoR, participates to the first edition of the “Journées québécoises de valorisation des données” organized by the Institute for Data Valorisation (IVADO) and the Big Data Research Centre (BDRC) of Université Laval to present the innovative business model of IRICoR.
As Université de Montréal’s drug discovery and […]
